The Alliance for Regenerative Medicine Applauds the Award of the Nobel Prize to CRISPR Pioneers

Washington, DC – October 7, 2020

ARM applauds the awarding of science’s highest honor – the Nobel Prize – for the discovery of the CRISPR method of genome editing, which our member companies are already deploying in pursuit of groundbreaking advancements against disease. In this extraordinary period of scientific innovation, CRISPR is one of several technologies in regenerative medicine that have the potential to deliver durable treatments – and even cures – for patients with both rare and more prevalent diseases and disorders.